Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells

International Journal of Laboratory Hematology

Volumn 32, Issue 1 PART.1, 2010, Pages

  Bairey, O ^a   Vanichkin, A ^a   Shpilberg, O ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; Arsenic trioxide; Bcl 2; Caspase 3; Chronic lymphocytic leukemia

Indexed keywords

ARSENIC TRIOXIDE; CASPASE 3; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL KILLING; CELL LEVEL; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LEUKEMIA CELL; MALE; PRIORITY JOURNAL;

APOPTOSIS; ARSENICALS; CELL SURVIVAL; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; OXIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 77249144468     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2008.01134.x     Document Type: Article

References (29)

1. Akao Y., Yamada H. & Nakaqawa Y. (2000) Arsenic-induced apoptosis in malignant cells in vitro. Leukemia & Lymphoma 37, 53-63.
2. Akao Y., Mizoguchi H., Kojima S., Naoe T., Ohishi N. & Yagi K. (1998) Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspase and down-regulation of Bcl-2 protein. British Journal Haematology 102, 1055-1060.
3. Antman K.H. (2001) Introduction: the history of arsenic trioxide in cancer therapy. Oncologist 6, 3-10.
4. Caligaris-Cappio F. & Hamblin T.J. (1999) B-cell chronic lymphocytic leukemia: a bird of a different feather. Journal of Clinical Oncology 17, 399-408.
5. Chen Y.C., Lin Shiau S.Y. & Lin J.K. (1998) Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. Journal of Cellular Physiology 177, 324-333.
6. 3 induces NB4 cell apoptosis with down regulation of Bcl-2 expression and modulation of PML-RARα/PML protein. Blood 88, 1052-1061.
7. Cuni S., Perez-Aciego P., Perez-Chacon G., Vargas J.A., Sanchez A., Martin- Saavedra F.M., Ballester S., Garcia- Marco J., Jorda J. & Durantez A. (2004) A sustained activation of PI3K/NF-kB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 18, 1391-1400.
8. Cutler E.G. & Bradford E.H. (1878) Action of iron, cod liver oil and arsenic on the globular richness of the blood. American Journal of the Medical Sciences 75, 74-84.
9. Douer D. & Tallman M.S. (2005) Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. Journal of Clinical Oncology 23, 2396-2410.
10. Er E., Oliver L., Cartron Pf., Juin P., Manon S. & Vallette F.M. (2006) Mitichondria as the target of the pro-apop- totic protein Bax. Biochimica et Biophysica Acta 1757, 1301-1311.
11. Gazit Y. & Akay C. (2005) Arsenic trioxide: an anticancer missile with multiple warheads. Hematology 10, 205-213.
12. Horie R., Wantabe M., Okamura T., Taira M., Shoda M., Motoji T., Utsunomiya A., Wantabe T., Higashihara M. & Umezawa K. (2006) DHMEQ, a new NF-kB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells. Leukemia 20, 800-806.
13. Kalmadi S.R. & Hussein M.A. (2006) The emerging role of arsenic trioxide as an immunomodulatory agent in the management of multiple myeloma. Acta Haematologica 116, 1-7.
14. Mathas S., Lietz A., Janz M., Hinz M., Jundt F., Scheidereit C., Bommert K. & Dorken B. (2003) Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-KB-related survival pathway down-regulation. Blood 102, 1028-1034.
15. Merkel O., Heyder C., Asslaber D., Ham- acher F., Tinhofer I., Holler C., Stocher M., Prokesch A., Papak C., Scheideler M., Trajanoski Z. & Greil R. (2008) Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13. Journal of Molecular Medicine 86, 541-552.
16. Murgo A.J. (2001) Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the national cancer institute cooperative research and development studies. Oncologist 6, 22-28.
17. Nakayama G.R., Caton M.C., Nova M.P. & Parandoosh Z. (1997) Assessment of the Almar Blue assay for cellular growth and viability in vitro. Journal of Immunoiogical Methods 204, 205-208.
18. Page B., Page M. & Noel N. (1993) A new fluorometric assay for cytotoxicity measurements in vitro. International Journal of Oncology 3, 473.
19. Rai K., Sawitsky A., Cronkite E., Chanana A.D., Levy R.N. & Pasternak B. (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46, 219-234.
20. Reed J.C. (1998) Molecular biology of chronic lymphocytic leukemia. Seminars in Oncology 25, 11-18.
21. Reed J.C. & Pellecchia M. (2005) Apoptosis-based therapies for hematologic malignancies. Blood 106, 408-418.
22. Scholz C., Richter A., Lehmann M., Schulze-Osthoff K., Dörken B. & Daniel P.T. (2005a) Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway. Oncogene 24, 7031-7042.
23. Scholz C., Wieder T., Starck L., Essmann F., Schulze-Osthoff K., Dorken B. & Daniel T.P. (2005b) Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway. Oncogene 24, 1904-1913.
24. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89, 3354-3360.
25. Tun-Kyi A., Qin J.Z., Oberholzer P.A., Navarini A.A., Hassel J.C., Dummer R. & Dobbeling U. (2008) Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model. Annals of Oncology 8, 1488-1494.
26. Verstovek S., Giles F., Quintas-Cardama A., Perez N., Ranavdi-Kashani F., Beran M., Freireich E. & Kantarjian H. (2006) Arsenic derivative in hematologic malignancies: a role beyond acute promyelocytic leukemia? Hematological Oncology 24, 181-188.
27. Zhang W., Ohnishi K., Shigeno K., Fujisawa S., Naito K., Nakamura S., Takeshita K., Takeshita A. & Ohno R. (1998) The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia 12, 1383-1391.
28. Zhu X.H., Shen Y.L., Jing Y., Cai X., Jia P.M., Huang Y., Tang W., Shi G.Y., Sun Y.P., Dai J., Wang Z.Y., Chen S.J., Zhang T.D., Waxman S., Chen Z. & Chen G.Q. (1999) Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. Journal of the National Cancer Institute 91, 772-778.
29. Zhu J., Okumura H., Ohtake S., Nakamura S. & Nakao S. (2003) Arsenic trioxide induces apoptosis in leukemia/ lymphoma cell lines via the CD95/ CD95L. Oncology Report 10, 705-709.